TipRanks
TipRanksTop Financial ExpertsInsidersLuke Evnin

Luke Evnin Insider Profile

4 Followers
Luke Evnin, Director at Werewolf Therapeutics, holds 0.00 shares in Werewolf Therapeutics (Ticker: HOWL), holds 6.36M shares in Poniard Pharmaceuticals (Ticker: PARD), holds ― shares in Syndax Pharmaceuticals (Ticker: SNDX).
See the Hottest Stocks Based on Insider Trading >
tipranks
Luke Evnin

Luke Evnin
Werewolf Therapeutics (HOWL)
Director

Ranked #59,436 out of 109,193 Corporate Insiders

Profitable Transactions

60%
3 out of 5 Profitable Transactions

Average Return

-2.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$40M
51.60%
48.40%
0.00%
0.00%
0.00% Others
A breakdown of Luke Evnin's holdings
See the Top Stocks by Insiders

Insider Roles

Pacira Pharmaceuticals
(PCRX)
Director
Altimmune
(ALT)
Ten Percent Owner
Werewolf Therapeutics
(HOWL)
Director
Poniard Pharmaceuticals
(PARD)
Ten Percent Owner
+1 other positions
Roles that Luke Evnin holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
ReShape Lifesciences
(~RSLS)
Rating:Informative Sell
Date:Jan 09, 2014 - Jan 09, 2015
Return:+52.30%
The most profitable trade made by Luke Evnin
See the Latest Stocks Traded by Insiders

Luke Evnin's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
HOWL
Werewolf Therapeutics
Jul 08, 2026
Director
Uninformative Sell
44.75K
$0.00
PARD
Poniard Pharmaceuticals
Nov 09, 2009
Ten Percent Owner
Uninformative Sell
4.05M
―
SNDX
Syndax Pharmaceuticals
―
Director, Ten Percent Owner
―
―
HARP
Harpoon Therapeutics
Feb 14, 2019
―
Informative Buy
3.50M
$104.11M
ONCR
Oncorus
Oct 08, 2020
―
Uninformative Buy
―
$314.10K
TMPM
Turmeric Acquisition
―
―
―
―
EPRSQ
Epirus Biopharma
Oct 28, 2011
―
Informative Sell
760.97K
$5.57M
PCRX
Pacira Pharmaceuticals
Jun 13, 2013
Director
Uninformative Sell
683.80K
$20.71M
EPZM
Epizyme
Feb 11, 2014
―
Informative Sell
13.65M
$3.55M
ALT
Altimmune
Nov 05, 2010
Ten Percent Owner
Informative Buy
7.67M
$19.42M
HGENQ
Humanigen
―
―
―
$28.96K
HSTOQ
Histogen
Aug 01, 2013
―
Uninformative Buy
183.88K
$13.11K
~RSLS
ReShape Lifesciences
Jan 09, 2014
―
Informative Sell
1.39M
$7.12M
SOMX
Somaxon Pharmaceuticals
―
―
―
―
~RDUS
Radius Health
Sep 29, 2016
―
Uninformative Sell
―
$58.78M
List of latest transactions for each holding click on a transaction to see Luke Evnin's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Luke Evnin insider profile FAQ

What is the percentage of profitable transactions made by Luke Evnin?
The percentage of profitable transactions made by Luke Evnin is 60%.
    What is the average return per transaction made by Luke Evnin?
    The average return per transaction made by Luke Evnin is -2.40%.
      What stocks does Luke Evnin hold?
      Luke Evnin holds: HOWL, PARD, SNDX, HARP, ONCR, TMPM, EPRSQ, PCRX, EPZM, ALT, HGENQ, HSTOQ, ~RSLS, SOMX, ~RDUS stocks.
        What was Luke Evnin’s latest transaction?
        Luke Evnin latest transaction was an Uninformative Sell of $44.75K.
          What was Luke Evnin's most profitable transaction?
          Luke Evnin’s most profitable transaction was an Informative Sell of ~RSLS stock on January 9, 2014. The return on the trade was 52.30%.
            What is Luke Evnin's role in Werewolf Therapeutics?
            Luke Evnin's role in Werewolf Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.